...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: BETonMACE Placebo Estimate

And why would a PAV of (-.6%) had RVX-208 reached that level would have been so earthshattering for the stock?

The (-.6%) seems so insignificant. And had it reached the (-.6%) back in 2013 would there be needed a follow-up trial before RVX208 ever sees the market place? And presumably, the (-1.43%)  PAV plague regression was reached with the help of the statin Crestor and typically the pre-specified (-.6%)  

Koo

Share
New Message
Please login to post a reply